Aim: Th e eff ects of dacarbazine, thiocolchicoside, methotrexate, olanzapine, pantoprazole sodium, and 5-fl uorouracil on the enzyme activity of glutathione reductase (GR) were studied using human erythrocyte GR enzymes in in vitro studies, respectively.
Introduction

Glutathione
(γ-L-glutamyl-L-cysteinylglycine; GSH) has many important functions. It is an antioxidant, is involved in the detoxifi cation of xenobiotics, and serves as a cofactor in isomerization reactions (1) . Glutathione has an important role in the synthesis and degradation of proteins, regulation of enzymes, formation of the deoxyribonucleotid precursors of deoxyribonucleic acid (DNA) and protection of cells against free radicals and reactive oxygen species (2) . Responsible for the reduction of GSSG to GSH is the enzyme glutathione reductase (GR; NADPH: oxidized glutathione oxidoreductase, EC 1.6.4.2), a fl avoprotein which uses NADPH as electron donor for the reduction reaction. GR enables several vital functions of the cell, such as the detoxifi cation of free radicals and reactive oxygen species as well as protein and DNA biosynthesis, by maintaining a high ratio of GSH/GSSG (3) . Decreased glutathione levels have also been reported in several diseases, such as acquired immune defi ciency syndrome (AIDS) (4), Parkinson's disease (5) , and diabetes (6, 7) . A major role of GSH in erythrocytes is the prevention of hemoglobin denaturation, preserving the integrity of erythrocyte membrane sulfh ydryl groups and detoxifi cation of the xenobiotics and reactive oxygen species in red blood cells (8) .
Many drugs have activation or inhibition eff ects on the body's enzyme systems (9) (10) (11) . Many drugs may show the same eff ects under both in vivo and in vitro conditions; however, some of them may not show the same eff ects on enzymes (12) (13) (14) . Both fl uorouracil (5-FU) and dacarbazine are used for treatments of some diff erent cancer diseases. Methotrexate is used in cancer chemotherapy. Contrary to these 3 drugs, thiocolchicoside is used for symptomatic treatment of painful muscle spasms; and while pantoprazole sodium is a proton pump inhibitor drug used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal refl ux disease olanzapine is a novel antipsychotic agent (15).
We have not encountered any studies on the eff ects of dacarbazine, thiocolchicoside, methotrexate, olanzapine, pantoprazole sodium, and 5-fl uorouracil on human erythrocyte GR activity. Th e objective of the present study was to investigate any possible in vitro eff ects of these drugs on purifi ed human erythrocyte GR.
Materials and methods
Materials
2' , 5'-ADP Sepharose 4B was purchased from Pharmacia. Sephadex G-200, NADPH, GSSG, the protein assay reagent and the chemicals for electrophoresis were purchased from Sigma Chem. Co. (Germany). All other chemicals used were analytical grade and purchased from either Merck or Sigma (Germany).
Preparation of the hemolysate
Fresh human blood from one single subject was collected into a tube containing 0.1 M Na-citrate, 0.16 M glucose, 0.016 M Na-phosphate, and 2.59 mM adenine for anticoagulation. Th e sample was centrifuged at 3000 × g for 15 min. Plasma and leukocyte coat were removed. Th e erythrocytes were washed three times with isotonic NaCl solution including 1 mM EDTA, the samples being centrifuged at 3000 × g each time and the supernatants removed. Th e washed erythrocytes were hemolyzed with 5 volumes of ice-cold distilled water containing 2.7 mM EDTA and 0.7 mM β-mercaptoethanol, and then centrifuged at 4 °C, 20,000 × g for 30 min to remove residual intact cells and membranes (16) .
Ammonium sulfate fractionation and dialysis
Th e hemolysate was subjected to precipitation with ammonium sulfate (between 30% and 70%). Enzyme activity was determined both in the supernatant and in the precipitate for each respective precipitation. Th e precipitate was dissolved in phosphate buff er (50 mM, pH 7.0). Th e resultant solution was clear, and contained partially purifi ed enzyme. Th is solution was dialyzed at 4 °C in 1 mM EDTA + 10 mM K-phosphate buff er (pH 7.5) for 2 h with 2 changes of buff er (12) . Partially purifi ed enzyme solution was kept at 4 °C.
2' , 5'-ADP Sepharose 4B affi nity chromatography
Dry 2' , 5'-ADP Sepharose 4B (2 g) was washed and swelled in distilled and deionized water. Aft er removal of the air in the gel, it was resuspended in 0.1 M Kacetate/0.1 M K-phosphate buff er, pH 6.0, and packed into a small column (1 × 10 cm). Aft er precipitation of the gel, it was equilibrated with the same buff er by means of a peristaltic pump with the fl ow rate adjusted to 20 mL/h. Th e dialyzed sample obtained from ammonium sulfate precipitation was loaded onto the column, and washed with 25 mL of 0.1 M K-acetate + 0.1 M K-phosphate, pH 6.0 and 25 mL of 0.1 M Kacetate + 0.1 M K-phosphate, pH 7.85. Washing continued with 50 mM of K-phosphate including 1 mM EDTA (pH 7.0) until the fi nal absorbance diff erence was 0.05 at 280 nm. Proteins bound on the gel were eluted with a gradient of 0-0.5 mMGSH and 0-1m M NADPH in 50 mM K-phosphate, containing 1 mM EDTA (pH 7.0). Active fractions were collected and dialyzed with 50 mM of K-phosphate including 1 mM EDTA (pH 7.0) at 4 °C (17) (18) (19) (20) .
Sephadex G-200 gel fi ltration chromatography
Dry Sephadex G-200 (5 g) was incubated in distilled water at 90 °C for 5 h. Aft er removal of the air in the gel, it was loaded onto a column (2 × 50 cm). Th e fl ow rate was adjusted to 15 mL/h by means of a peristaltic pump. Th e column was equilibrated with 50 mM Tris-HCl, and 50 mM KCl buff er (pH 7.0) until the fi nal absorbance diff erence became 0 at 280 nm and the pH was the same as that of the equilibration buff er. Th e dialyzate from the affi nity chromatography column was mixed with glycerol in a proportion of 5%. Th e fi nal sample was loaded onto the column and 2 mL of each elution was collected. Th e absorbance values were determined at 280 nm and 340 nm in each fraction (11) . Active fractions were lyophilized and stored at -85 °C for use in the in vitro studies.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
To determine the enzyme's purity, SDS-PAGE was performed according to Laemmli's method (21) . Th e acrylamide concentration of the stacking and separating gels was 3% and 8%, respectively, and 1% SDS was also added to the gel solution. Th e gel was stained for 2 h in 0.1% Coomassie Brilliant Blue R-250 containing 50% methanol, 10% acetic acid and 40% distilled water. Th en the gel was washed with many changes of the same solvent without dye. Cleared protein bands were photographed (Figure 1 ).
Activity assay
Glutathione reductase activity was determined by the method of Carlberg and Mannervik (22) with a Shimadzu Spectrophotometer UV-(1208) at 25 °C. Th e assay system contained 40 mM Tris-HCl buff er, pH 8.0, including 0.8 mM EDTA, 1 mM GSSG, and 0.1 mM NADPH in 1 mL total reaction volume. Th e activity was measured by monitoring the decrease in absorbance at 340 nm due to the oxidation of NADPH at 25 °C. One enzyme unit is defi ned as the oxidation of 1 μmol NADPH per min under the assay conditions.
Protein determination
Quantitative protein determination was performed spectrophotometrically at 595 nm according to Bradford's method (23), using bovine serum albumin as a standard. Qualitative protein determination was also performed spectrophotometrically at 280 nm according to Segel's method (24) .
In vitro drug studies
Dacarbazine, thiocolchicoside, methotrexate, olanzapine, pantoprazole sodium, and 5-fl uorouracil tested to determine their eff ects on human erythrocyte GR activity. Assays were performed in cuvette concentrations of 0.004-0.053 mM dacarbazine, 0.035-0.14 mM thiocolchicoside, 0.022-1.1 mM methotrexate, 0.16-0.96 mM olanzapine, 0.24-1.96 mM pantoprazole sodium, and 19.22- 
Results
Th e purifi cation of the enzyme led to a specifi c activity of 4 EU/mg protein, a yield of 44.44% and a purifi cation coeffi cient of 3333. SDS polyacrylamide gel electrophoresis was performed aft er the purifi cation of the enzyme, and the electrophoretic pattern was photographed (Figure 1) . IC 50 values of dacarbazine, thiocolchicoside, methotrexate, olanzapine, pantoprazole sodium, and 5-fl uorouracil were 0.014, 0.054, 0.31, 0.35, 0.94, and 98.57 mM, respectively, and the Ki constants were 0.0121 ± 0.0026, 0.0135 ± 0.0024, 0.1213 ± 0.040, 0.3173 ± 0.0981, 0.5413 ± 0.0728, and 69.611 ± 9.690 mM respectively (Table) . Representative graphs are shown for dacarbazine (Figures 2 and 3) . Inhibition types were non-competitive for dacarbazine, methotrexate, olanzapine, and 5-fl uorouracil and competitive for thiocolchicoside and pantoprazole sodium.
Discussion
Enzymatic defense is provided by many enzyme systems such as glutathione reductase, glutathione peroxidase, glutathione S transferase (GST), superoxide dismutase, catalase, aldoketoreductase, and DNA repair enzymes (25) . Glutathione reductase catalyzes the reduction of GSSG in the presence of NADPH, with the latter being produced in the pentose phosphate metabolic pathway. GSH is a product of the reaction catalyzed by glutathione reductase, and the GSH-related enzyme system is one of the most important protective systems in cells. Reduced glutathione is used in the detoxifi cation of xenobiotics, protection of the thiol groups of intracellular proteins, scavenging of H 2 O 2 and other organic peroxides, and counteraction of oxidative events. Th e fi rst step, in the detoxifi cation of xenobiotics, consists of GSH conjugates owing to its high nucleophilic potency (27) .
Many chemicals and drugs are known to have adverse or benefi cial eff ects on human enzyme and metabolic events, and the eff ects can be dramatic and systemic (28) . Th e inhibition of some important enzymes plays a key role in a metabolic pathway, e.g. some metabolic diseases are aff ected by enzyme activity (29) . Similarly, acetazolamide has an inhibitory eff ect on the carbonic anhydrase (CA) enzyme leading to diuresis (30) . Additionally, epiandrosterone was found to inhibit red blood cell glucose 6-phosphate dehydrogenase (G6PD) uncompetitively and suppress hexose monophosphate shunt activity by more than 95% (31) . Some chemicals and drugs, such as nitrofurazone, (32) , and polyphenolic compounds, also inhibit GR enzyme activity (32) . Furthermore, it is reported that human erythrocyte GR, human erythrocyte CA-I and CA-II, human erythrocyte G6PD and human erythrocyte 6PGD are inhibited by some drugs and chemicals (11) (12) (13) (14) (34) (35) (36) (37) (38) (39) .
Dacarbazine can induce a marked reduction of blast cells as well as severe myelotoxicity in leukemic patients (40) . Methotrexat inhibits the metabolism of a-oxoaldehydes in vivo in leukemic children, as a likely consequence of glyoxalase I inhibition (41) . When methotrexat was used as a chemotherapy drug, it was seen that ALT rises 14% and AST rises 8%. Aft er the drug is discontinued enzymes turn to normal (42).
In the present paper, the eff ects of some commonly used drugs on human erythrocyte GR enzyme were investigated. In order to show inhibitory eff ects, while the most suitable parameter is the Ki constant, some researchers use the IC 50 value. Th erefore, in this study, both the Ki and IC 50 parameters of these drugs for GR were determined.
IC 50 values of dacarbazine, thiocolchicoside, methotrexate, olanzapine, pantoprazole sodium, and 5-fl uorouracil were 0.014, 0.054, 0.31, 0.35, 0.94, and 98.57 mM, and the Ki constants were 0.0121 ± 0.0026, 0.0135 ± 0.0024, 0.1213 ± 0.040, 0.3173 ± 0.0981, 0.5413 ± 0.0728, and 69.611 ± 9.690 mM, respectively. Ki constants show that dacarbazine had the highest inhibitory eff ect, followed by thiocolchicoside, methotrexate, olanzapine, pantoprazole sodium, and 5-fl uorouracil, in that order. IC 50 values showed the same trend. In this investigation, by using the obtained Ki constants and IC 50 values, undesirable side eff ects of these drugs on GR activity and body metabolism and antioxidative capacity can be reduced.
Th e Table shows that the enzyme is mostly  inhibited by dacarbazine, thiocolchicoside, methotrexate, olanzapine, and pantoprazole sodium drugs. Th e chemical structures of all these drugs contain an active group of carbonyl and nitrogen. Only olanzapine does not contain a carbonyl group. Moreover, thiocolchicoside and olanzapine contain sulfur groups and methotrexate contains hydroxyl groups. 5-Fluorouracil, which has a less inhibitory eff ect on the enzyme's activity, contains carbonyl, fl uoride, and nitrogen groups, but does not contain sulfur and hydroxyl groups.
Th e dosages of the examined drugs (iv) used clinically give blood drug concentrations as follows; dacarbazine ~4, thiocolchicoside ~58, methotrexate ~315, olanzapine ~455, pantoprazole sodium ~345, and 5-fl uorouracil ~532 mM (19) . By taking into account these concentrations, the inhibition data calculated from plots were found to be 2%, 13%, 23%, 1%, 0.4%, 0%, and 0.1%, respectively. According to these data, if patients are required to be given thiocolchicoside and methotrexate, their dosage should be very well controlled to decrease hemolytic and other side eff ects due to possible inhibition of GR.
